Medio Labs is an innovative biotechnology company that has developed the patent-pending platform, MedioSeq, which offers pathogen detection labs an opportunity to significantly increase throughput, lower cost and generate more data faster through a conversion of their qPCR panels to a consolidated NGS workflow. With MedioSeq enabling the everyday use of NGS, it is now possible to process more panels, targets per panel and samples with less space, personnel, instruments and consumables.
MedioSeq’s broad applications include human diagnostics, as well as veterinary, agricultural, environmental and food testing.
Having successfully used its own innovation of MedioSeq to process thousands of Covid-19 samples per day during the height of the pandemic, Medio Labs is now focused on helping labs process their pathogen panels with greater scale and efficiency.
To discuss streamlining your pathogen testing workflows with MedioSeq, send an email to info@medio.ai and we will be in touch!
Company Details
- Employees
- 4
- Founded
- -
- Address
- 5980 Horton St,
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://medio.ai
- Keywords
- Emeryville.
- HQ
- Emeryville, California
Medio Labs Questions
Medio Labs's website is https://medio.ai
Medio Labs's LinkedIn profile is https://www.linkedin.com/company/mediolabs
Medio Labs has
4 employees.
View email and phone details for 4
employees at Medio Labs.
Medio Labs's industry is
Biotechnology Research
Medio Labs's top competitors are
Ergobility,
Lyfeatlas,
Brainworks,
Enrichment.kids,
Infinite Entertainment,
Tlt Llc,
Zinexts Life Science Corp.,
Astalake Bio,
Bioacumen Global Pte Ltd,
Proportional.
Medio Labs's categories are Biotechnology Research
Medio Labs's founding year is 2020
